Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001117 | 72.0212 | 0.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 74.0367 | 1.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 90.0318 | 1.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 113.9929 | 0.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 116.0107 | 1.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 116.0471 | 2.19 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 117.9357 | 24.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 126.0082 | 0.95 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 129.0430 | 0.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 129.9666 | 0.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 130.0630 | 4.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 130.0630 | 4.59 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 131.0943 | 1.82 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 131.0944 | 1.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 131.9514 | 24.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | L-[15N]ANTHRANILIC ACID [ISTD] (M-H)- | 138.0447 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |
| AN001117 | 144.0937 | 8.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 146.0497 | 4.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 148.0369 | 1.06 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 148.0511 | 2.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 159.9855 | 0.57 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 161.8489 | 0.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 165.0193 | 1.08 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 165.0789 | 2.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 166.0396 | 7.46 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 169.0509 | 0.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 175.9630 | 0.58 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 176.0317 | 1.57 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 180.0556 | 5.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 181.9799 | 0.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | CYSTEIC ACID (M-H)- | 187.0187 | 0.73 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |
| AN001117 | 187.1205 | 7.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 188.0082 | 0.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 188.0457 | 0.96 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 189.0982 | 1.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 189.0990 | 5.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 191.0788 | 0.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 191.0789 | 1.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 193.0561 | 12.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 193.0738 | 5.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 194.0941 | 15.12 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 195.0893 | 17.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 196.0033 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 196.8177 | 0.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 198.0501 | 4.19 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 198.0502 | 4.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 201.8661 | 23.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 202.0453 | 0.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 202.0454 | 2.92 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 203.1157 | 1.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 203.1157 | 8.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 205.0122 | 0.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 206.0320 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 206.0425 | 1.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | L-TRYPTOPHAN-15N2 [ISTD] (M-H)- | 206.0842 | 3.65 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |
| AN001117 | 210.0924 | 14.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 215.1522 | 12.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 216.0404 | 1.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 218.0434 | 0.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 219.0742 | 1.58 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 221.0412 | 0.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 222.1001 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 222.1408 | 8.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 222.1615 | 20.24 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 223.0221 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 223.0375 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 226.0187 | 5.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 226.1566 | 14.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 226.1569 | 15.82 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 227.9408 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 227.9733 | 0.58 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 229.0711 | 0.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 229.1678 | 14.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 230.0406 | 1.29 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 230.1417 | 9.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 230.1419 | 10.15 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 231.8766 | 23.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 232.0696 | 0.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 232.0700 | 1.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 232.1416 | 1.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 233.0663 | 2.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 233.9821 | 1.01 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 234.0272 | 7.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 234.1622 | 19.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 237.0998 | 8.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 237.9698 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 237.9794 | 1.29 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 238.0986 | 3.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 238.0996 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 240.0996 | 9.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 240.1359 | 16.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 240.1513 | 8.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 241.0563 | 1.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 242.0613 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 242.2244 | 22.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 243.1840 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 244.1783 | 6.12 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 244.1784 | 6.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 244.2034 | 20.45 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 245.0537 | 1.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 245.1266 | 1.87 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 245.1451 | 16.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 246.0509 | 0.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 246.1208 | 1.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 249.0388 | 1.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 250.0581 | 5.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 250.1567 | 21.96 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 251.1013 | 0.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 251.1520 | 21.09 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 252.1032 | 14.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 252.1103 | 3.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 252.2089 | 22.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 253.0946 | 1.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 254.0688 | 3.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 254.1518 | 14.79 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 255.1826 | 16.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 255.1827 | 16.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 256.2402 | 22.22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 256.2403 | 23.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 256.9671 | 1.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 257.1145 | 6.44 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 257.1990 | 17.26 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 257.9621 | 0.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 257.9622 | 6.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 258.0350 | 1.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 258.0561 | 18.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 258.0849 | 1.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 258.8857 | 0.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 259.1603 | 18.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 260.1371 | 4.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 261.0664 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 262.0795 | 0.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 262.0796 | 1.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 263.9177 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 264.0435 | 3.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 265.1174 | 3.95 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 265.1657 | 15.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 265.1682 | 21.79 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 266.1553 | 20.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 268.0024 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 268.0734 | 0.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 269.1049 | 19.57 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 270.0949 | 0.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 270.2186 | 21.49 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 270.2192 | 21.09 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 271.0711 | 0.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 271.2148 | 18.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 272.0777 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 272.2346 | 21.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 272.2346 | 22.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 272.2350 | 21.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 272.2350 | 22.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 272.2351 | 21.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 272.9931 | 1.01 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 273.0607 | 0.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 273.0973 | 0.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 273.1935 | 15.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 273.1939 | 16.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 273.9451 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 274.0713 | 3.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 274.2144 | 22.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 276.0288 | 0.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 276.0951 | 1.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 276.1109 | 3.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 276.1766 | 22.05 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 277.0257 | 1.61 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 277.1677 | 21.49 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 278.0247 | 6.79 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 278.1880 | 19.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 278.2240 | 22.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 279.1313 | 1.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 279.1315 | 0.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 279.1602 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 280.0459 | 1.44 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 280.0627 | 1.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 280.1710 | 21.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 281.0432 | 0.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 281.1114 | 0.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 282.1070 | 3.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 282.2557 | 22.37 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 282.2565 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 283.0729 | 0.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 283.1395 | 12.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 283.2146 | 18.93 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 284.1175 | 23.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 284.1408 | 6.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 284.1412 | 8.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 284.2722 | 23.28 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 287.0978 | 3.23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 287.1920 | 21.12 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 288.0955 | 2.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 290.0319 | 0.82 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 290.1087 | 7.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 290.1089 | 12.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 290.9517 | 2.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 291.0940 | 1.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 291.2041 | 16.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 292.1915 | 15.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 293.1412 | 3.65 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 293.1477 | 1.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 294.0706 | 3.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 294.1827 | 17.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 294.1829 | 17.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 294.1863 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 294.1864 | 22.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 294.1866 | 23.29 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 295.1927 | 16.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 296.0577 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 296.1967 | 22.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 297.0895 | 4.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 297.1558 | 14.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 297.1919 | 16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 298.0716 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 298.1157 | 1.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 298.1413 | 10.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 298.1605 | 21.41 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 298.2497 | 22.46 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 298.2506 | 21.79 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 298.2506 | 22.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 298.2872 | 23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 300.0978 | 5.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 300.1030 | 21.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 300.2648 | 22.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 300.2659 | 22.17 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 300.9804 | 2.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 300.9897 | 1.21 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 301.1422 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 301.2065 | 21.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 301.2256 | 18.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 302.0636 | 2.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 302.0718 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 302.1664 | 10.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 302.2206 | 15.15 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 302.2256 | 22.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 302.2454 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 303.1051 | 1.15 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 304.0908 | 1.43 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 304.2401 | 22.06 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 305.2201 | 16.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 306.1792 | 15.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 306.2554 | 22.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 306.2559 | 22.96 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 307.0840 | 0.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 307.0842 | 1.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 307.9448 | 6.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 308.1195 | 9.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 308.1195 | 10.17 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 308.2022 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 308.2714 | 23.09 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 309.0062 | 3.22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 309.1429 | 3.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 310.1539 | 22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 310.1777 | 17.23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 310.1805 | 21.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 311.0088 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 311.1710 | 15.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 312.0314 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 312.1077 | 0.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 312.1078 | 1.11 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 312.1761 | 22.26 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 312.1763 | 22.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 312.1796 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 312.2051 | 21.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 313.1325 | 16.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 313.9799 | 13.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 314.2414 | 22.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 315.1073 | 0.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 315.1079 | 1.08 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 316.1815 | 12.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 316.2602 | 21.15 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 318.1049 | 1.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 318.1065 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 320.2350 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | THYMIDINE 5'-MONOPHOSPHATE (M-H)- | 322.0573 | 1.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |
| AN001117 | 322.0702 | 0.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 322.2146 | 22.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 322.2498 | 22.12 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 324.0369 | 0.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 324.2275 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 324.2658 | 22.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 326.1918 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 326.1920 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 327.1321 | 2.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 328.1610 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 328.2576 | 22.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 328.2614 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 328.2618 | 22.58 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 329.0664 | 1.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 329.1056 | 21.79 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 329.1241 | 1.82 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 330.0090 | 5.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 330.1312 | 7.87 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 330.1984 | 14.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 330.2559 | 22.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 330.2767 | 23.23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 331.1244 | 3.22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 331.1370 | 2.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 332.1219 | 2.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 332.1617 | 12.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 332.1625 | 15.79 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 332.2305 | 15.02 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 332.2714 | 23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 333.9680 | 1.02 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 334.0988 | 12.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 334.0999 | 9.25 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 334.1005 | 1.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 334.1010 | 1.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 334.1181 | 9.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 334.1420 | 20.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 334.2860 | 22.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 334.2870 | 23.19 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 336.0758 | 0.79 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 336.3024 | 23.4 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 337.3342 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 338.2439 | 23.01 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 339.2019 | 18.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 340.2070 | 24.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 340.2219 | 21.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 342.1491 | 22.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 342.2756 | 23.23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 343.0947 | 4.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 343.1083 | 15.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 343.1259 | 1.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.0987 | 0.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.1459 | 9.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.1471 | 10.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.1776 | 21.1 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.1777 | 20.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.1777 | 20.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.2128 | 16.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.2135 | 14.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 344.9839 | 3.22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 345.1414 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 345.2878 | 21.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 346.1415 | 6.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 346.1418 | 7.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 346.1422 | 8.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 346.1784 | 14.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 347.0621 | 0.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 348.1198 | 5.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 348.1572 | 11.88 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 348.1576 | 8.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 348.1775 | 21.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 348.1933 | 14.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 348.2279 | 22.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 350.0822 | 0.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 350.1144 | 10.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 350.2433 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 351.3101 | 22.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 352.0142 | 3.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 352.0416 | 12.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 352.0874 | 1.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 352.1393 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 352.2240 | 18.88 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 352.2593 | 23.25 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 354.0144 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 354.0556 | 12.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 354.0563 | 11.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 354.1498 | 22.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 354.1723 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 354.2081 | 22.19 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 354.2400 | 17.13 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 354.2782 | 23.05 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 355.2550 | 22.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 356.1426 | 1.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 356.1655 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 356.2931 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 356.3278 | 22.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 357.1374 | 22.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 357.2685 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 357.2879 | 22.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 358.0525 | 0.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 358.2291 | 17.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 358.2884 | 23.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 360.0419 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 360.1419 | 10.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 360.3018 | 23.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 361.0003 | 1.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 361.1344 | 1.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 362.0970 | 1.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 362.1134 | 1.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 362.1366 | 6.32 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 362.3181 | 23.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 363.0338 | 1.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 363.1085 | 2.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 364.1515 | 5.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 364.3338 | 23.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 365.3297 | 23.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 365.9842 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 366.0555 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 366.1250 | 12.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 366.1250 | 13.01 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 366.1250 | 13.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 366.1427 | 3.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 366.2245 | 18.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 366.2535 | 22.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 368.0846 | 5.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 368.2196 | 16.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 368.2248 | 23.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 368.2681 | 22.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 369.0562 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 369.1403 | 3.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 369.2446 | 20.02 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 369.9899 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 370.1540 | 10.92 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 370.2814 | 18.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 371.3013 | 22.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 371.3030 | 20.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 371.3040 | 21.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 372.2295 | 22.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 372.2973 | 22.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 373.1116 | 1.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 373.1329 | 22.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 373.1406 | 15.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 373.1677 | 22.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 373.3115 | 23.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 374.0909 | 10.12 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 374.0911 | 9.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 374.2671 | 22.37 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 375.2894 | 22.96 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 376.0134 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 376.0380 | 11.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 376.1066 | 10.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 376.2596 | 23.09 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 376.2826 | 22.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 377.1064 | 1.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 378.2760 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 378.2804 | 22.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 379.1035 | 1.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 379.1580 | 15.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 380.1634 | 22.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 380.1637 | 22.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 380.1666 | 22.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 380.1877 | 22.97 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 380.2775 | 23.01 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 382.1182 | 8.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 382.1820 | 22.97 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 382.2053 | 23.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 382.2782 | 22.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 383.0435 | 1.92 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 383.1077 | 3.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 383.3394 | 23.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 384.1339 | 8.88 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 384.1971 | 23.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 384.3241 | 23.13 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 385.1514 | 0.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 385.3190 | 22.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 385.9634 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 386.1472 | 3.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 386.1944 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 387.1213 | 4.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 387.2415 | 21.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 387.9605 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 388.1566 | 14.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 388.3336 | 23.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 389.1627 | 21.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 389.1628 | 20.36 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 389.1628 | 20.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 389.1628 | 22.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 389.1629 | 21.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 389.3050 | 22.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 390.2016 | 22.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 390.2967 | 22.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 391.1200 | 1.82 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 391.1787 | 19.44 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 392.1468 | 8.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 392.2963 | 23.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 392.3643 | 24.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 393.0190 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 393.0749 | 1.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 394.1014 | 0.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 394.2871 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 395.1185 | 2.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 396.0347 | 5.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 396.2498 | 22.57 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 396.2505 | 18.59 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 396.2527 | 22.25 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 397.2233 | 19.41 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 397.3188 | 22.44 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 397.3189 | 22.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 398.1690 | 3.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 398.1851 | 14.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 398.3397 | 23.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 399.1494 | 22.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 399.2415 | 22.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 399.3332 | 23.09 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 399.3348 | 22.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 400.2579 | 23.01 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 401.1643 | 22.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 401.1645 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 401.3496 | 22.59 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 402.0862 | 9.25 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 402.0867 | 12.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 402.1200 | 3.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 402.2978 | 22.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 403.3223 | 23.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 404.0985 | 8.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 404.1011 | 8.58 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 404.1139 | 3.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 404.1655 | 22.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 404.1720 | 22.92 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 404.3145 | 23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 405.0530 | 1.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 405.1562 | 5.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 405.1571 | 4.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 405.1587 | 18.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 405.1599 | 1.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 406.1118 | 3.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 406.1165 | 8.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 406.1788 | 22.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 406.3049 | 23.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 407.1324 | 0.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 407.1381 | 1.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 407.1489 | 6.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 407.1692 | 2.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 408.1743 | 1.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 409.0761 | 1.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 409.1309 | 10.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 409.1310 | 9.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 409.1372 | 8.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 410.1735 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 410.1750 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 410.2137 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 410.2820 | 22.57 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 410.3167 | 23.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 411.3350 | 23.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 411.9736 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 412.2114 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 413.1708 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 413.2002 | 22.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 413.3133 | 22.16 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 413.3477 | 23.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 413.3508 | 22.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 413.3515 | 23.28 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 414.1098 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 414.1280 | 6.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 414.1288 | 7.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 414.1289 | 8.41 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 414.1293 | 8.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 415.1750 | 14.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 415.3294 | 20.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 415.3295 | 21.95 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 415.3298 | 21.58 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 415.3299 | 21.15 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 415.3299 | 22.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 415.3300 | 21.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 415.3652 | 23.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 416.1447 | 8.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 417.0286 | 2.87 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 417.3371 | 23.43 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 417.3451 | 22.02 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 417.3453 | 21.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 418.1621 | 0.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 418.2306 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 418.2923 | 21.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 418.2928 | 22.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 420.0546 | 2.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 420.0947 | 14.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 420.2470 | 23.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 420.3072 | 21.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 420.3094 | 22.57 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 420.3260 | 23.29 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 421.2054 | 1.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.0130 | 0.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.0434 | 11.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.1441 | 7.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.1500 | 16.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.1626 | 18.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.2346 | 22.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.2353 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.2849 | 22.08 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 422.3171 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 423.0939 | 1.25 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 423.1058 | 0.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 423.1459 | 10.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 423.2389 | 20.22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 424.1303 | 12.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 424.2817 | 22.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 424.3067 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 424.3338 | 23.06 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 425.1052 | 2.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 425.1389 | 1.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 425.2541 | 21.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 425.2545 | 21.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 426.0873 | 0.73 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 426.2158 | 17.43 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 426.2967 | 22.73 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 426.3709 | 23.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 427.0569 | 2.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 427.1505 | 4.57 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 427.1825 | 22.96 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 427.3657 | 23.43 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 428.3302 | 23.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 429.1146 | 0.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 429.1950 | 23.24 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 429.3433 | 22.65 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 429.3435 | 22.88 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 429.3446 | 22.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 430.0646 | 0.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 430.0820 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 430.0874 | 16.09 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 430.0948 | 7.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 430.1210 | 14.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 430.1240 | 6.32 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 430.1897 | 22.96 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 430.2020 | 22.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 431.3241 | 21.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 431.3580 | 22.43 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 432.1551 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 432.1785 | 16.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 432.1913 | 18.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 432.2037 | 23.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 432.3454 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 433.2857 | 22.24 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 434.1116 | 13.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 434.1118 | 12.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 434.1125 | 13 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 434.1336 | 3.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 434.1471 | 21.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 434.1544 | 0.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 435.1311 | 3.23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 435.1499 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 435.2151 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 436.1109 | 7.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 436.1245 | 3.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 436.1801 | 19.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 436.1921 | 22.97 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 436.3544 | 23.11 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 436.3664 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 437.2604 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 437.2914 | 22.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 438.2057 | 23.22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 438.3113 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 438.3497 | 23.36 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 439.1407 | 9.87 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 439.1444 | 2.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 439.3032 | 22.61 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 440.1446 | 6.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 441.0981 | 1.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 441.1225 | 2.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 441.1298 | 15.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 441.1400 | 5.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 441.2305 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 441.3816 | 23.61 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 442.0839 | 9.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 443.3416 | 22.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 443.3999 | 23.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 443.9200 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 444.0254 | 11.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 444.0926 | 10.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 444.1165 | 8.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 444.1478 | 2.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 444.1783 | 15.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 444.2542 | 23.05 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 444.3119 | 20.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 445.0373 | 1 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 446.1119 | 12.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 446.1267 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 446.1944 | 18.36 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 446.2070 | 19.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 446.3233 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 447.1454 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 447.3823 | 23.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 448.1420 | 18.26 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 448.1716 | 0.71 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 448.2953 | 21.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 448.3347 | 23.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 448.3404 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 449.1621 | 11.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 449.2559 | 21.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 450.1577 | 17.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 450.1765 | 18.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 450.3166 | 22.59 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 451.1420 | 0.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 451.2704 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 452.3114 | 23.13 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 452.3135 | 22.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 453.1539 | 0.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 453.2850 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 453.2867 | 22.22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 453.3763 | 23.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 454.3305 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 454.3402 | 20.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 454.3407 | 20.82 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 454.3652 | 22.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 455.1178 | 11.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 455.1188 | 12.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 455.2121 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 456.0716 | 14.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 457.1509 | 22.02 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 457.2259 | 23.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 458.0580 | 0.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 458.1538 | 6.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 458.2334 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 458.3614 | 23.34 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 458.3707 | 21.94 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 460.1561 | 14.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 460.2030 | 3.23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 460.2053 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 460.2098 | 19.19 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 460.2099 | 17.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 460.2099 | 19.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 460.2101 | 18.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 460.3754 | 23.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 461.3356 | 20.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 463.2455 | 1.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 463.3062 | 22.65 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 465.3210 | 22.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 465.3215 | 22.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 465.3224 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 466.1716 | 14.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 466.2741 | 24.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 467.3376 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 468.3553 | 21.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 469.1361 | 0.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 469.1365 | 1.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 470.0728 | 12.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 470.2765 | 22.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 471.3308 | 20.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 472.1675 | 1.15 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 472.3434 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 474.1037 | 8.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 474.2904 | 25.88 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 474.2918 | 22.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 474.3109 | 22.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 474.3129 | 22.08 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 475.0900 | 2.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 475.2690 | 21.77 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 475.3359 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.0995 | 8.41 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.0998 | 8.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.1281 | 14.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.1974 | 0.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.2044 | 19.37 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.2046 | 18.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.2046 | 18.92 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.2046 | 19.82 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 476.3283 | 22.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 477.2856 | 22.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 478.1146 | 8.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 478.1607 | 1.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 478.3491 | 22.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 479.3020 | 22.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 479.3024 | 22.37 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 480.1680 | 9.24 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 480.1880 | 2.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 480.2026 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 480.3020 | 22.09 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 480.3813 | 22.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 481.1518 | 11.17 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 481.1529 | 9.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 481.3164 | 22.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 481.3201 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 482.1133 | 3.49 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 482.1161 | 8.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 482.1162 | 6.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 482.1171 | 8.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 482.1711 | 18.37 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 482.3734 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 483.2409 | 23.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 484.1321 | 8.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 484.2799 | 24.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 484.3872 | 21.08 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 485.2746 | 24.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 486.2198 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 487.2849 | 24.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 488.2344 | 23.26 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 488.3129 | 10.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 488.3349 | 19.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 489.0871 | 20.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 489.0871 | 20.65 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 489.2509 | 17.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 490.2219 | 22.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 490.3126 | 22.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 492.0681 | 8.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 492.1742 | 0.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 492.1996 | 18.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 492.1998 | 18.97 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 492.2000 | 17.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 492.2003 | 16.73 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 492.2005 | 17.88 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 492.3673 | 23.97 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 493.2417 | 21.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 495.3345 | 22.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 496.1197 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 496.3509 | 20.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 496.3853 | 22.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 498.0902 | 1.01 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 498.1097 | 6.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 498.1796 | 0.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 498.3641 | 19.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 499.2706 | 21.69 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 499.3556 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 500.0699 | 3.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 500.1375 | 3.63 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 500.3709 | 22.26 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 501.2864 | 22.06 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 502.3427 | 22.58 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 503.2799 | 21.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 503.2954 | 22.06 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 503.3017 | 22.36 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 503.3032 | 22.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 504.3598 | 22.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 505.1430 | 3.44 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 505.3168 | 22.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 506.2588 | 3.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 506.3938 | 23.28 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 507.3334 | 22.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 507.3341 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 508.0910 | 0.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 508.3486 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 509.3487 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 510.0979 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 510.2956 | 25.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 510.2961 | 24.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 510.4029 | 22.26 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 511.2734 | 23.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 511.2937 | 20.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 512.0821 | 10.21 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 512.3838 | 21.7 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 513.2695 | 24.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 513.3069 | 21.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 513.3069 | 21.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 513.3415 | 20.29 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 514.1533 | 0.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 514.1612 | 9.87 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 514.1617 | 10.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 514.2529 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 515.1323 | 15.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 515.2865 | 24.59 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 516.1293 | 18.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 516.3236 | 19.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 517.2275 | 0.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 517.2299 | 1.08 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 517.2450 | 21.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 519.2575 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 521.1135 | 20.36 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 521.1137 | 20.65 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 521.2733 | 22.21 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 522.1568 | 22.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 523.2906 | 22.79 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 523.2908 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 525.1798 | 21.41 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 525.2508 | 16.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 525.2861 | 22.07 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 526.1478 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 526.3509 | 19.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 526.3514 | 19.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 527.1714 | 13.05 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 527.3020 | 22.23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 528.1194 | 3.22 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 528.1437 | 14.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 528.1908 | 22.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 529.2631 | 24.17 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 529.3177 | 22.46 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 530.2860 | 20.18 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 531.2451 | 1.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 531.2830 | 24.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 531.3334 | 23.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 531.3339 | 22.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 533.3478 | 22.98 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 533.3481 | 22.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 534.1602 | 14.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 534.2973 | 24.56 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 535.3652 | 23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 535.3655 | 23.28 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 537.3070 | 21.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 539.3227 | 22.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 539.3228 | 21.84 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 540.2860 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 540.2864 | 20.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 540.2877 | 20.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 541.0610 | 1.08 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 541.0619 | 0.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 541.3379 | 22.36 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 541.3386 | 22.52 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 542.1499 | 6.25 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 542.3447 | 18.13 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 542.3453 | 18.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 542.3456 | 18.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 542.3461 | 17.8 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 543.3404 | 19.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 544.0879 | 8.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 544.0885 | 8.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 544.3938 | 23.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 545.1820 | 1.04 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 545.2793 | 22.03 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 546.1031 | 8.88 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 546.2719 | 13.41 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 546.3019 | 24.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 547.2032 | 0.73 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 547.2894 | 22.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 548.1892 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 549.1544 | 8.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 549.1560 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 549.2010 | 1.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 549.3048 | 22.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 550.1031 | 8.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 550.1938 | 3.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 550.1964 | 0.73 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 550.2047 | 23.26 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 551.1954 | 21.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 552.1192 | 8.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 553.0990 | 3.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 553.2106 | 22.23 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 553.3164 | 22.43 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 553.3766 | 22.93 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 554.2057 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 554.3023 | 21.39 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 554.3034 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 554.5012 | 24.28 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 555.1287 | 1.19 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 555.2127 | 21.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 555.3328 | 22.62 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 555.4860 | 23.86 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 556.1265 | 1.05 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 556.1396 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 556.2225 | 23.27 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 557.3305 | 22.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 557.3484 | 22.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 557.3509 | 22.97 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 557.5013 | 24.02 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 559.2473 | 22.05 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 560.3675 | 22.97 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 560.4728 | 22.97 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 560.4832 | 22.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 561.2287 | 21.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 561.3798 | 23.08 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 561.3799 | 23.28 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 562.1353 | 0.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 563.3957 | 23.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 565.1999 | 2.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 565.3300 | 23.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 565.3380 | 22.15 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 565.3452 | 22.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 565.3510 | 23.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 565.3523 | 22.59 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 566.0545 | 0.85 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 566.3066 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 566.3246 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 566.4635 | 22.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 567.2576 | 21.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 567.3537 | 22.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 567.3541 | 22.64 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 568.3183 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 568.4803 | 23.06 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 569.2740 | 22.06 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 569.3115 | 24.2 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 569.3683 | 22.87 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 569.3687 | 22.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 570.3163 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 570.3440 | 23.33 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 571.2905 | 22.35 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 572.1114 | 0.67 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 572.1974 | 9.6 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 572.3269 | 21.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 572.4990 | 22.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 572.5039 | 24.9 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 573.3054 | 22.55 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 573.4888 | 24.32 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 574.3032 | 15.14 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 574.3087 | 22.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 574.4485 | 23.31 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 574.4983 | 22.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 575.3203 | 22.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 575.5034 | 24.54 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 576.2825 | 14.72 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 576.3311 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 578.2628 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 578.2978 | 13.42 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 579.2268 | 22.37 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 581.1749 | 0.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 581.2249 | 1.48 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 581.2431 | 22.76 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 581.2909 | 21.78 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 581.2942 | 21.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 581.3420 | 22.38 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 581.5030 | 23.99 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 582.2973 | 20.3 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 582.3320 | 22.02 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 582.5338 | 24.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 583.5178 | 24.32 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 584.3105 | 19.53 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 584.5002 | 22.65 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 585.1592 | 0.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 585.2428 | 21.51 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 585.3800 | 23.01 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 585.5325 | 24.5 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 586.2949 | 15.83 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 586.3348 | 23.81 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 586.3512 | 21.91 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 586.4847 | 23.32 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 587.1756 | 15.47 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 587.2486 | 21.74 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 587.3072 | 21.19 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 588.0879 | 0.68 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 588.1353 | 0.75 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 588.5064 | 22.66 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 588.5150 | 22.89 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001117 | 589.2617 | 22.21 | Minutes | ST000714 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |